There is no single leading cause of Alzheimer’s disease. Instead, the condition results from a combination of age-related brain changes, genetic predisposition, and lifestyle factors that interact over decades. Brain changes linked to Alzheimer’s can begin 10 or more years before any memory symptoms appear, and the disease currently affects an estimated 7.2 million Americans aged 65 and older. Understanding the major contributors helps clarify why some people develop the disease and others don’t.
Age Is the Strongest Risk Factor
More than any other variable, getting older increases the likelihood of Alzheimer’s. About 5% of people aged 65 to 74 have the disease. That number jumps to 13% for those aged 75 to 84, and reaches 33% for people 85 and older. The number of people living with Alzheimer’s roughly doubles every five years beyond age 65.
Aging doesn’t cause Alzheimer’s directly, but it sets the stage. Over time, the brain accumulates damage from oxidative stress, reduced blood flow, and a declining ability to clear waste products. These gradual shifts create an environment where the hallmark proteins of Alzheimer’s can build up and spread.
What Happens Inside the Brain
Two abnormal proteins define Alzheimer’s at a biological level. The first, called amyloid-beta, clumps together into sticky plaques between brain cells. The second, called tau, forms tangled fibers inside neurons. Current evidence suggests amyloid-beta acts first, triggering a chain reaction that leads to tau-related damage. Once tau tangles spread, they disrupt the internal scaffolding that neurons depend on to transport nutrients and communicate with each other.
These two proteins appear to fuel each other in a damaging feedback loop. Amyloid plaques generate oxidative damage that radiates outward into surrounding brain tissue, particularly in the hippocampus, the region most closely tied to memory formation. As neurons lose their structural integrity, synapses (the connections between brain cells) begin to fail, and cells eventually die. This process unfolds silently for years before a person notices any cognitive changes.
The Role of the Brain’s Immune System
The brain has its own immune cells, called microglia, that normally serve a protective role. They clear debris, help maintain connections between neurons, and even support memory formation. In the early stages of Alzheimer’s, microglia attempt to eat and remove amyloid plaques.
As the disease progresses, though, microglia become chronically activated and shift from helpful to harmful. They pump out inflammatory molecules that damage surrounding tissue, and their ability to clear amyloid plaques declines. This creates a vicious cycle: plaques accumulate faster, inflammation worsens, and neurons suffer increasing damage. Genetic mutations affecting microglia can further impair this cleanup process, accelerating the buildup of toxic proteins.
Genetics and the APOE4 Gene
The single most significant genetic risk factor for late-onset Alzheimer’s is a gene variant called APOE4. Everyone inherits two copies of the APOE gene (one from each parent), and the version you carry influences your risk substantially. People who inherit two copies of APOE4 have roughly a 60% chance of developing Alzheimer’s dementia by age 85. A 2024 NIH-supported study found that nearly all people with two APOE4 copies showed Alzheimer’s brain pathology from age 55 onward, compared with about half of those without the variant.
Carrying one copy of APOE4 raises risk to a lesser degree. Still, most people with APOE4 never develop Alzheimer’s, and many people without it do. The gene influences how efficiently the brain clears amyloid-beta, but it is not a guarantee of disease. Other, rarer genetic mutations can cause Alzheimer’s with near certainty, but these account for a very small fraction of all cases and typically cause symptoms before age 65.
Vascular Health and Blood Flow
The brain consumes an enormous amount of blood and oxygen relative to its size, so anything that compromises blood flow can accelerate Alzheimer’s pathology. Hypertension, diabetes, and high cholesterol are all associated with significantly increased risk, and their effects may be additive or even synergistic.
High blood pressure damages the blood-brain barrier, a tightly sealed layer of cells that controls what enters brain tissue. When this barrier weakens, the brain loses its ability to efficiently flush out amyloid-beta through dedicated transport channels, allowing plaques to accumulate faster. Hypertension also increases amyloid deposits in and around blood vessels, compounding the damage.
Diabetes shifts amyloid-beta into more toxic forms and amplifies the brain’s inflammatory response, even in areas without visible plaques. It also disrupts multiple signaling pathways involved in how neurons process information and survive. High levels of an amino acid called homocysteine, often linked to poor diet and B-vitamin deficiency, add further oxidative stress and can trigger tiny bleeds in the brain’s blood vessels.
14 Modifiable Risk Factors
A landmark 2024 report from The Lancet Commission on dementia identified 14 modifiable risk factors that, taken together, account for a meaningful share of dementia cases worldwide. These span the entire lifespan:
- Less education in early life
- Hearing loss
- Hypertension
- Smoking
- Obesity
- Depression
- Physical inactivity
- Diabetes
- Excessive alcohol consumption (more than 12 U.S. standard drinks per week)
- Traumatic brain injury
- Air pollution
- Social isolation
- Untreated vision loss
- High LDL cholesterol
The last two were added in the 2024 update based on newly compelling evidence. None of these factors alone is likely to cause Alzheimer’s, but each one chips away at the brain’s resilience over time. Addressing even a few of them, particularly in midlife, can meaningfully reduce overall risk.
Why Women Are Affected More Often
Nearly two-thirds of Americans with Alzheimer’s are women. The most straightforward explanation is longevity: women live longer than men on average, and since age is the dominant risk factor, more women reach the ages where the disease is most common. There are roughly 5.7 million more women than men in the older age brackets in the U.S.
Biology may also play a role. Women have stronger immune systems than men, which is generally protective, but that stronger immune response may lead to greater production of amyloid plaques. Amyloid-beta appears to function partly as an immune defense molecule, so a more active immune system could paradoxically increase plaque buildup over a lifetime.
How These Causes Interact
What makes Alzheimer’s so difficult to prevent or treat is that these factors don’t operate in isolation. A person with APOE4, poorly controlled blood pressure, and limited physical activity faces compounding risks. The amyloid buildup driven by genetics accelerates under conditions of reduced blood flow. Chronic inflammation from vascular disease feeds the same inflammatory cycle that overactivated microglia are already driving. And all of it worsens with the natural wear of aging.
The disease is best understood not as having one cause, but as a threshold problem. The brain can absorb a remarkable amount of damage before symptoms appear. Cognitive reserve, built through education, social engagement, and physical activity, raises that threshold. Genetic risk, vascular disease, and chronic inflammation lower it. Alzheimer’s develops when accumulated damage crosses the line the brain can no longer compensate for, which is why the path to disease looks different for every person.